Access cutting-edge i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. treatment through this clinical trial at a research site in Chapel Hill. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Chapel Hill location
Access i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. treatment provided free
Check if you qualify for this i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. clinical trial in Chapel Hill, NC
No-Cost Study Care
Local to Chapel Hill
Convenient for NC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study will look at control of blood sugar levels in persons with type 2 diabetes mellitus currently on chronic dialysis. Researchers will compare blood sugar levels in people taking semaglutide to people taking "dummy" medicine. The treatment participants get will be decided randomly. Participants will need to inject the study medication once a week. The study will last for 1 year and a month. Participants will be asked to wear a sensor that measures blood sugar levels for a period of 10 d
Sponsor: University of Texas Southwestern Medical Center
Yes, this clinical trial (NCT06042153) has an active research site in Chapel Hill, NC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. treatment options in Chapel Hill, NC, this clinical trial (NCT06042153) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chapel Hill research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all i cannot determine the primary medical condition from the provided information. the study title "dialysis-tir study" suggests it involves dialysis patients, but the conditions listed only show drug names (semaglutide and placebo) rather than medical conditions, and the brief summary appears to be incomplete (showing only a localhost url). to properly extract the primary patient-facing condition, i would need the actual medical conditions or indications listed in the study details. clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Chapel Hill — not just this study.
Browse Multiple Myeloma Trials in Chapel Hill →